Mizuho Securities USA LLC Sells 10,279 Shares of Colgate-Palmolive (NYSE:CL)

Mizuho Securities USA LLC reduced its holdings in shares of Colgate-Palmolive (NYSE:CL) by 16.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 52,984 shares of the company’s stock after selling 10,279 shares during the period. Mizuho Securities USA LLC’s holdings in Colgate-Palmolive were worth $5,500,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Pacer Advisors Inc. boosted its holdings in Colgate-Palmolive by 18.8% during the third quarter. Pacer Advisors Inc. now owns 111,272 shares of the company’s stock valued at $11,551,000 after purchasing an additional 17,623 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after buying an additional 557,492 shares in the last quarter. Integrated Investment Consultants LLC raised its stake in Colgate-Palmolive by 369.4% during the third quarter. Integrated Investment Consultants LLC now owns 13,566 shares of the company’s stock worth $1,408,000 after acquiring an additional 10,676 shares in the last quarter. Tradewinds LLC. raised its stake in Colgate-Palmolive by 3.9% during the third quarter. Tradewinds LLC. now owns 58,126 shares of the company’s stock worth $6,034,000 after acquiring an additional 2,170 shares in the last quarter. Finally, Intech Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 48.9% in the 3rd quarter. Intech Investment Management LLC now owns 132,417 shares of the company’s stock valued at $13,746,000 after purchasing an additional 43,481 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.5 %

NYSE CL opened at $94.37 on Friday. Colgate-Palmolive has a 12 month low of $75.50 and a 12 month high of $109.30. The stock has a 50-day simple moving average of $98.32 and a 200 day simple moving average of $98.50. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $77.10 billion, a PE ratio of 27.04, a P/E/G ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CL shares. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. UBS Group lifted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Thursday, November 14th. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.